Two-dose vaccines induce lower antibodies against Omicron, study finds

photo

Two-dose COVID-19 vaccine regimens do not induce enough neutralising antibodies against the Omicron coronavirus variant, British scientists found, indicating that increased infections in those previously infected or vaccinated may be likely. Researchers from the University of Oxford published results on Monday from a study yet to be peer-reviewed, where they analysed blood samples from participants … Read more

Coronavirus vaccine update: Results show Oxford University-AstraZeneca COVID-19 vaccine can be 90% effective

vaccine 7

A volunteer receives an injection at the Chris Hani Baragwanath hospital in Soweto, Johannesburg, as part of Africa’s first participation in a COVID-19 vaccine trial developed at the University of Oxford in Britain in conjunction with the pharmaceutical company AstraZeneca. (AP photo/FILE) The University of Oxford and Britain’s AstraZeneca announced on Monday that the Covid-19 … Read more

As pandemic continues across the globe, where are we in the coronavirus vaccine race?

photo

NEW YORK: Drugmakers and research centers around the world are working on COVID-19 vaccines, with large global trials of several of the candidates involving tens of thousands of participants well underway. As some companies close in on unveiling their initial findings – with Canadian and European regulators already reviewing early data on some vaccines – … Read more

Phase-III trial of Oxford vaccine to begin in Pune next week

photo

PUNE: The phase-III human clinical trial of the COVID-19 vaccine developed by Oxford University and being manufactured by the Serum Institute of India (SII) will begin at the Sassoon General Hospital in Pune next week. Dean of the state-run Sassoon General Hospital Dr Muralidhar Tambe told this to PTI on Saturday. “The phase-III trial of … Read more

South African volunteers on AstraZeneca vaccine trial say not alarmed by pause

photo

JOHANNESBURG: South African volunteers on AstraZeneca‘s experimental coronavirus vaccine trial said they were not worried to hear the trial had been paused after a participant fell ill and they hoped to be part of a potential solution to the pandemic. The vaccine, developed with the University of Oxford, has been described by the World Health … Read more

AstraZeneca COVID-19 vaccine study paused after one illness

photo

New York: Late-stage studies of AstraZeneca‘s COVID-19 vaccine candidate are on temporary hold while the company investigates whether a recipient’s “potentially unexplained” illness is a side effect of the shot. In a statement issued on Tuesday evening, the company said its “standard review process triggered a pause to vaccination to allow review of safety data”. … Read more

Serum Institute initiates phase 2, 3 clinical study for potential COVID-19 vaccine

photo

New Delhi: Indian pharmaceutical giant Serum Institute of India has initiated the phase 2, 3 clinical trials to evaluate the safety and immune response of coronavirus vaccine candidate on healthy Indian adults after the pharma company got approval from Drugs Controller General of India (DCGI) earlier this month. According to the Clinical Trial Registry India, … Read more

Once we get vaccine, COVID-19 warriors will be first ones to get a dose, says MoS Health

photo

NEW DELHI: Scientists are working hard on coronavirus vaccine and if their efforts bear fruit, COVID-19 warriors will be the first ones to get the dose, Union Minister of State for Health Ashwini Kumar Choubey said on Saturday. Interacting with reporters on the sidelines of the Independence Day celebrations at the Red Fort here, he … Read more

King dollar’s decline ripples across the globe

photo

An accelerating decline in the US dollar is reverberating around the world, adding fuel to a global momentum rally that has boosted prices for everything from technology stocks to gold. The US dollar index, which measures the greenback against six other major currencies, is down around 9% from its March highs and is on track … Read more

Three Covid vaccine developers report promising initial results from human trials

photo

By David D. Kirkpatrick LONDON: The race for a vaccine against the coronavirus intensified Monday as three competing laboratories released promising results from early trials in humans. Now comes the hard part: proving that any of the vaccines protects against the virus and establishing how much immunity they provide — and for how long. “What … Read more